416 Participants Needed

Lifestyle Changes for Gestational Diabetes

(TLC Trial)

CM
AR
Overseen ByAmber R Ivins, MS
Age: Any Age
Sex: Female
Trial Phase: Academic
Sponsor: University of North Carolina, Chapel Hill
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 3 JurisdictionsThis treatment is already approved in other countries

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your healthcare provider.

What data supports the effectiveness of the treatment TLC Group Prenatal Care, Targeted Lifestyle Change Group Prenatal Care, Group Prenatal Care, CenteringPregnancy for gestational diabetes?

Research shows that lifestyle changes, including diet and exercise, can effectively control blood sugar levels in pregnant women with gestational diabetes, with 82.6% achieving successful control. Additionally, group-based prenatal care programs have shown improvements in patient knowledge, empowerment, and pregnancy outcomes.12345

Is the lifestyle change program for gestational diabetes safe for humans?

The research does not specifically address safety concerns, but lifestyle modification programs, like those used in diabetes prevention, are generally considered safe for humans as they focus on healthy diet and physical activity.56789

How is the TLC Group Prenatal Care treatment different from other treatments for gestational diabetes?

The TLC Group Prenatal Care treatment is unique because it focuses on lifestyle changes and group support during pregnancy, rather than medication, to help manage gestational diabetes. This approach emphasizes healthy habits and community support, which can be more suitable for pregnant women who may not be able to use certain medications.7891011

What is the purpose of this trial?

To conduct a randomized trial to determine the effect of Targeted Lifestyle Change Group Prenatal Care (TLC) on maternal and neonatal outcomes in women at high risk for developing gestational diabetes mellitus (GDM).

Research Team

EB

Ebony B Carter, MD, MPH

Principal Investigator

University of North Carolina, Chapel Hill

Eligibility Criteria

This trial is for English-speaking women under 16 weeks pregnant, at high risk for gestational diabetes due to factors like being overweight, inactive, having a family history of diabetes or certain ethnic backgrounds. They must be able to attend group prenatal visits and agree to random assignment in the study.

Inclusion Criteria

You have two or more of the following: high body mass index (BMI), physical inactivity, a close family member with diabetes, belong to a high-risk race or ethnicity, had a previous large baby, had gestational diabetes before, have high blood pressure, low levels of "good" cholesterol or high triglycerides, polycystic ovarian syndrome, high blood sugar levels, history of heart disease, can attend group prenatal visits on specific days and times, are willing to be randomly assigned to a group, and can provide informed consent.
English speaking
โ‰ค16 weeks' gestation

Exclusion Criteria

You have tested positive for high blood sugar during early pregnancy.
I have type 2 diabetes.
Multiple gestation (require extra care)
See 3 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive Targeted Lifestyle Change Group Prenatal Care (TLC) starting in the late first trimester or early second trimester, focusing on education about pregnancy, exercise/nutrition, and behavioral health.

6-10 sessions
6-10 visits (in-person)

Follow-up

Participants are monitored for maternal and neonatal outcomes, including psychosocial stress and depression, up to 12 weeks postpartum.

4-12 weeks postpartum

Treatment Details

Interventions

  • TLC Group Prenatal Care
Trial Overview The study is testing Targeted Lifestyle Change Group Prenatal Care (TLC) to see if it improves outcomes for mothers and babies at risk of gestational diabetes. Women will be randomly placed into groups where they receive this specialized care during pregnancy.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: TLC Group Prenatal CareExperimental Treatment1 Intervention
TLC will start in the late first trimester or early second trimester and run for \~6-10 sessions. Groups of 2-10 consented women, with two or more GDM risk factors, will meet under the supervision of an obstetric provider (nurse practitioner or MD) and co-facilitator (health educator, nutritionist, or nurse) for two-hour sessions. A major focus of TLC will be education, and much of each visit will be spent on pregnancy, exercise/nutrition education, and behavioral health.
Group II: Traditional Prenatal CareActive Control1 Intervention
Subjects randomized to routine care will receive their prenatal care with their primary obstetric provider. Patients are seen for 10-15 minutes every four weeks until 28 weeks' gestation, every two weeks (or more by provider discretion) until 37 weeks and weekly until delivery. Visits focus on routine screening tests and prenatal care. Traditional care participants will receive a phone call once a month, until 28 weeks gestation, from a nurse practitioner to check-in on pregnancy goals, healthy eating, and exercise. Each subject's medical chart will be reviewed for demographics, antenatal management, maternal and neonatal outcomes.

TLC Group Prenatal Care is already approved in United States, European Union, Canada for the following indications:

๐Ÿ‡บ๐Ÿ‡ธ
Approved in United States as Group Prenatal Care for:
  • Prenatal care for high-risk pregnancies
  • Prevention of gestational diabetes mellitus (GDM)
๐Ÿ‡ช๐Ÿ‡บ
Approved in European Union as CenteringPregnancy for:
  • Prenatal care for low-risk pregnancies
  • Improvement of maternal and neonatal outcomes
๐Ÿ‡จ๐Ÿ‡ฆ
Approved in Canada as Group Prenatal Care for:
  • Prenatal care for high-risk pregnancies
  • Prevention of preterm birth

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of North Carolina, Chapel Hill

Lead Sponsor

Trials
1,588
Recruited
4,364,000+

Washington University School of Medicine

Lead Sponsor

Trials
2,027
Recruited
2,353,000+

American Diabetes Association

Collaborator

Trials
148
Recruited
102,000+

Findings from Research

In a study of 1035 pregnant women, 82.6% achieved successful glycemic control after just two weeks of lifestyle changes, including diet and exercise, highlighting the effectiveness of these interventions for managing gestational diabetes mellitus (GDM).
Younger women (under 35) and those with a pre-pregnancy BMI under 25 had significantly higher rates of glycemic control, suggesting that age and weight management are important factors in the success of lifestyle interventions for GDM.
The Effectiveness of Lifestyle Changes in Glycemic Control among Pregnant Women with Gestational Diabetes Mellitus.Le, DC., Vu, TB., Tran, TN., et al.[2023]
Women with gestational diabetes who successfully managed their condition through lifestyle modifications were generally younger and had a lower pre-pregnancy body mass index compared to those who required medication, suggesting that these factors may influence glycemic control outcomes.
The study identified specific diagnostic parameters, such as glucose challenge test and fasting oral glucose tolerance test results, that can help predict which women are likely to need anti-diabetic medications instead of achieving control through lifestyle changes alone.
Characterization of women with gestational diabetes who failed to achieve glycemic control by lifestyle modifications.Krispin, E., Ashkenazi Katz, A., Shmuel, E., et al.[2021]
Integrating group-based lifestyle sessions (GBLS) into prenatal care shows promise for managing gestational weight gain, with positive feedback from both care providers and patients.
Preliminary data from two feasibility studies suggest that while GBLS can positively influence weight gain patterns, there is a need for more research on its implementation and effectiveness in various settings.
Group-based lifestyle sessions for gestational weight gain management: a mixed method approach.Harden, SM., Beauchamp, MR., Pitts, BH., et al.[2014]

References

The Effectiveness of Lifestyle Changes in Glycemic Control among Pregnant Women with Gestational Diabetes Mellitus. [2023]
Characterization of women with gestational diabetes who failed to achieve glycemic control by lifestyle modifications. [2021]
Group-based lifestyle sessions for gestational weight gain management: a mixed method approach. [2014]
The Gestational Diabetes Group Program. [2020]
The effect of a diabetes prevention program on dietary quality in women with previous gestational diabetes. [2020]
Glycemic control, compliance, and satisfaction for diabetic gravidas in centering group care. [2019]
7.United Arab Emiratespubmed.ncbi.nlm.nih.gov
Strategies for diabetes prevention before and after pregnancy in women with GDM. [2022]
Reliability and Validity of Measures for Investigating the Determinants of Health Behaviors Among Women With a History of Gestational Diabetes. [2019]
Linking Postpartum and Parenting Women With a National Diabetes Prevention Program: Recruitment Efforts, Challenges, and Recommendations. [2020]
Lifestyle intervention for the prevention of type 2 diabetes in women with prior gestational diabetes: A systematic review and meta-analysis. [2023]
A randomised translational trial of lifestyle intervention using a 3-tier shared care approach on pregnancy outcomes in Chinese women with gestational diabetes mellitus but without diabetes. [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of ServiceยทPrivacy PolicyยทCookiesยทSecurity